Myriad's BRCA Gene Patents Struck Down In Court; Are Biotech's Foundations Shaking?

Judge finds that isolated DNA is not different from that in the body and thus unpatentable; Myriad says its products are covered by other patents.

More from Archive

More from Pink Sheet